458 related articles for article (PubMed ID: 3015560)
1. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
[TBL] [Abstract][Full Text] [Related]
2. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
[TBL] [Abstract][Full Text] [Related]
3. The effects of 1,25-dihydroxyvitamin D3 on growth, alkaline phosphatase and adenylate cyclase of rat osteoblast-like cells.
Pols HA; Schilte HP; Herrmann-Erlee NM; Visser TJ; Birkenhäger JC
Bone Miner; 1986 Oct; 1(5):397-405. PubMed ID: 2849488
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids and 1,25-dihydroxyvitamin D3 regulate parathyroid hormone stimulation of adenosine 3',5'-monophosphate-dependent protein kinase in rat osteosarcoma cells.
Titus L; Rubin JE; Lorang MT; Catherwood BD
Endocrinology; 1988 Sep; 123(3):1526-34. PubMed ID: 2456915
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: relationship to adenylate cyclase activation.
Titus L; Jackson E; Nanes MS; Rubin JE; Catherwood BD
J Bone Miner Res; 1991 Jun; 6(6):631-7. PubMed ID: 1653516
[TBL] [Abstract][Full Text] [Related]
7. 1,25-dihydroxyvitamin D-3 and 24,25-dihydroxyvitamin D-3 affect parathormone (PTH) -sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action.
Klem KH; Jablonski G; Saether O; Jarosz G; Gautvik KM; Gordeladze JO
Biochim Biophys Acta; 1990 Sep; 1054(3):304-10. PubMed ID: 2169895
[TBL] [Abstract][Full Text] [Related]
8. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
[TBL] [Abstract][Full Text] [Related]
9. Modulation of parathyroid hormone-sensitive adenylate cyclase in ROS 17/2.8 cells by dexamethasone 1,25-dihydroxyvitamin D3 and protein kinase C.
Rao LG; Wylie JN
Bone Miner; 1993 Oct; 23(1):35-47. PubMed ID: 8274878
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxycholecalciferol and glucocorticosteroid regulation of adenylate cyclase in an osteoblast-like cell line.
Catherwood BD
J Biol Chem; 1985 Jan; 260(2):736-43. PubMed ID: 2578454
[TBL] [Abstract][Full Text] [Related]
11. The effect of 1,25-dihydroxyvitamin D3 on human osteoblast-like osteosarcoma cell: modification of response to PTH.
Ikeda K; Imai Y; Fukase M; Fujita T
Biochem Biophys Res Commun; 1990 May; 168(3):889-97. PubMed ID: 2161222
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells.
Manolagas SC; Burton DW; Deftos LJ
J Biol Chem; 1981 Jul; 256(14):7115-7. PubMed ID: 6941964
[TBL] [Abstract][Full Text] [Related]
13. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
14. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
Marcus R; Orner FB; Brickman AS
Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats.
Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
Endocrinology; 1982 Oct; 111(4):1339-44. PubMed ID: 6981502
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells.
Klaus G; von Eichel B; May T; Hügel U; Mayer H; Ritz E; Mehls O
Endocrinology; 1994 Oct; 135(4):1307-15. PubMed ID: 7523093
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol.
Rao LG; Sutherland MK; Reddy GS; Siu-Caldera ML; Uskokovic MR; Murray TM
Bone; 1996 Dec; 19(6):621-7. PubMed ID: 8968029
[TBL] [Abstract][Full Text] [Related]
18. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
Spiess YH; Price PA; Deftos JL; Manolagas SC
Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
[TBL] [Abstract][Full Text] [Related]
19. Effects of dexamethasone and vitamin D3 on cartilage differentiation in a clonal chondrogenic cell population.
Grigoriadis AE; Aubin JE; Heersche JN
Endocrinology; 1989 Oct; 125(4):2103-10. PubMed ID: 2551636
[TBL] [Abstract][Full Text] [Related]
20. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
